Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Stroke

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 115 articles: HTML format

Single Articles

October 2026
1. SHAW JR, Xu Y
   After THA or TKA, aspirin alone was noninferior to rivaroxaban then aspirin for symptomatic VTE at 90 d.
   Ann Intern Med. 2026;179:JC116.
   PubMed     Abstract available
   
   
   
2. FATH AR, Elgendy IY
   After PCI in patients with ACS, short-duration DAPT followed by P2Y12 inhibitor monotherapy vs. standard DAPT reduces NACE.
   Ann Intern Med. 2026;179:JC118.
   PubMed     Abstract available
   
   
   September 2026
3. ALSAARAN Z, Hill MD
   In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d.
   Ann Intern Med. 2026 Sep 1. doi: 10.7326/ANNALS-26-03132.
   PubMed     Abstract available
   
   
   
4. GUL S
   In thrombolysis-treated AIS, early DAPT improved functional outcomes at 90 d without increasing symptomatic ICH.
   Ann Intern Med. 2026;179:JC103.
   PubMed     Abstract available
   
   
   August 2026
5. CAI A, Bayes-Genis A, Wolfe R, Tonkin AM, et al
   Longitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults : An Observational Study.
   Ann Intern Med. 2026 Aug 18. doi: 10.7326/ANNALS-26-00245.
   PubMed     Abstract available
   
   
   
6. YANG Y, Shen CY, Cheng MC, Kang W, et al
   Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.
   Ann Intern Med. 2026 Aug 11. doi: 10.7326/ANNALS-25-04740.
   PubMed     Abstract available
   
   
   
7. SRIVASTAVA A, Sharma M
   In large-core ischemic stroke with onset in the past 24 h, EVT vs. medical therapy improves functional outcomes and reduces mortality at 90 d.
   Ann Intern Med. 2026 Aug 4. doi: 10.7326/ANNALS-26-02780.
   PubMed     Abstract available
   
   
   
8. HILL MD
   In noncardioembolic ischemic stroke or high-risk TIA, asundexian reduced ischemic stroke and did not increase major bleeding.
   Ann Intern Med. 2026 Aug 4. doi: 10.7326/ANNALS-26-02578.
   PubMed     Abstract available
   
   
   July 2026
9. RACO M, Raco D
   In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.
   Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-26-02439.
   PubMed     Abstract available
   
   
   June 2026
10. DAMEN JAA, Idema DL, Vernooij RWM, Huis In 't Veld LF, et al
    Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
    Ann Intern Med. 2026 Jun 16. doi: 10.7326/ANNALS-24-03764.
    PubMed     Abstract available
    
    
    
11. FIELD TS
    In basilar artery occlusion, tenecteplase within 24 h of symptom onset improved functional outcome vs. usual care at 90 d.
    Ann Intern Med. 2026 Jun 2. doi: 10.7326/ANNALS-26-01704.
    PubMed     Abstract available
    
    
    May 2026
12. LIP GYH
    In cardiology outpatients at high stroke risk, smartwatch-based screening vs. usual care increased detection of new onset AF at 180 d.
    Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-26-01144.
    PubMed     Abstract available
    
    
    
13. LO B
    Tenecteplase 4.5 to 24 h after non-LVO stroke with potentially salvageable brain tissue improved functional outcomes at 90 d.
    Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-26-01142.
    PubMed     Abstract available
    
    
    
14. ALBERTS MJ
    In acute ischemic stroke, adding minocycline to standard care increased excellent functional outcome rates at 90 d.
    Ann Intern Med. 2026 May 5. doi: 10.7326/ANNALS-26-01362.
    PubMed     Abstract available
    
    
    April 2026
15. SHAIK H, Jillella D
    After ischemic stroke in patients receiving aspirin, switching to another antithrombotic regimen does not reduce recurrence.
    Ann Intern Med. 2026 Apr 7. doi: 10.7326/ANNALS-26-00772.
    PubMed     Abstract available
    
    
    March 2026
16. DONATO A
    In adults at high CV risk and without previous MI or stroke, evolocumab reduced major adverse CV event composites at a median 4.6 y.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05604.
    PubMed     Abstract available
    
    
    
17. DODD TS, Borzak S
    After successful catheter ablation for AF, rivaroxaban did not reduce a composite of stroke or systemic embolism vs. aspirin at 36 mo.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05629.
    PubMed     Abstract available
    
    
    February 2026
18. DAWWAS GK, Lewis JD, Tedla YG, Cuker A, et al
    The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol.
    Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-01408.
    PubMed     Abstract available
    
    
    
19. CARPENTER CR
    Alteplase and aspirin within 4.5 h of severe vision loss due to CRAO did not differ for improvement in visual acuity at 1 mo.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05284.
    PubMed     Abstract available
    
    
    
20. SHARMA M, Srivastava A
    In patients with ischemic stroke, NVAF, and ASCVD, adding an antiplatelet to OAC therapy did not affect net clinical benefit at 2 y.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05308.
    PubMed     Abstract available
    
    
    
21. KELSEY MD
    In patients with CAD, clopidogrel vs. aspirin monotherapy reduces MACCE without increasing major bleeding.
    Ann Intern Med. 2026;179:JC16.
    PubMed     Abstract available
    
    
    December 2025
22. YAN VKC, Blais JE, Gamble JM, Chan EWY, et al
    Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.
    Ann Intern Med. 2025 Dec 30. doi: 10.7326/ANNALS-25-00662.
    PubMed     Abstract available
    
    
    
23. STEEN JP, Klatt KC, Chang Y, Guyatt GH, et al
    Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events : A Risk Stratified Systematic Review of Randomized Trials.
    Ann Intern Med. 2025 Dec 16. doi: 10.7326/ANNALS-25-02229.
    PubMed     Abstract available
    
    
    
24. GUL S, Uchino K
    Alteplase 4.5 to 24 h after stroke with potentially salvageable brain tissue increased independence at 90 d.
    Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04796.
    PubMed     Abstract available
    
    
    
25. GUL S, Uchino K
    In anterior circulation LVO stroke, adding IV alteplase to thrombectomy increased intracranial hemorrhage at 7 d.
    Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04797.
    PubMed     Abstract available
    
    
    
26. MEI DA, Romiti GF
    In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y.
    Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04685.
    PubMed     Abstract available
    
    
    
27. LEIVA O, Elgendy IY
    In adults with MI and LVEF >40% after invasive care, beta-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y.
    Ann Intern Med. 2025;178:JC134.
    PubMed     Abstract available
    
    
    
28. LEIVA O, Elgendy IY
    In adults with MI and LVEF >/=40%, beta-blocker therapy reduced a composite adverse outcome at a median 3.5 y.
    Ann Intern Med. 2025;178:JC135.
    PubMed     Abstract available
    
    
    
29. LIM LS
    In healthy older adults, low-dose aspirin for a median 4.7 y did not reduce MACE but increased major hemorrhage at a median 8.3 y.
    Ann Intern Med. 2025;178:JC139.
    PubMed     Abstract available
    
    
    November 2025
30. GANDH AS, Siddu M, Jillella D
    In minor stroke, adding IV thrombolysis to nonthrombolytic usual care does not increase excellent functional outcome at 90 d.
    Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-04399.
    PubMed     Abstract available
    
    
    
31. GODOY A, Douketis JD
    In cancer-associated thrombosis, DOACs reduce VTE and increase clinically relevant nonmajor bleeding vs. LMWH at 3 to 12 mo.
    Ann Intern Med. 2025;178:JC127.
    PubMed     Abstract available
    
    
    September 2025
32. JUNG M, Reisert M, Rieder H, Rospleszcz S, et al
    Association Between Body Composition and Cardiometabolic Outcomes : A Prospective Cohort Study.
    Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-24-01863.
    PubMed     Abstract available
    
    
    
33. KOTANIDIS CP, Gorey S, Marwah H, Pearl A, et al
    Revision of Research Abstracts Through the Editorial Process.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-02250.
    PubMed    
    
    
    
34. KHAN F, Hill MD
    In carotid stenosis with low or intermediate risk for stroke, adding revascularization to OMT did not improve outcomes at 2 y.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03078.
    PubMed     Abstract available
    
    
    
35. LO BM
    In acute ischemic stroke with large core infarct, EVT improves mRS scores but increases symptomatic intracranial hemorrhage at 90 d.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03146.
    PubMed     Abstract available
    
    
    
36. ALBERTS MJ
    In ischemic stroke prevention, apixaban and aspirin do not differ for intracranial hemorrhage events.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03295.
    PubMed     Abstract available
    
    
    
37. FIELD TS
    In AIS due to LVO presenting within 4.5 h of onset, adding tenecteplase to EVT increased functional independence at 90 d.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03337.
    PubMed     Abstract available
    
    
    August 2025
38. SMITH KC, Gaziano TA, Mushlin AI, Cutler DM, et al
    Effect of Systolic Blood Pressure Measurement Error on the Cost-Effectiveness of Intensive Blood Pressure Targets.
    Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-00560.
    PubMed     Abstract available
    
    
    
39. FIELD TS
    At 4.5 to 24 h after posterior circulation stroke onset, alteplase vs. standard medical care increased 90-d functional independence.
    Ann Intern Med. 2025 Aug 5. doi: 10.7326/ANNALS-25-02446.
    PubMed     Abstract available
    
    
    July 2025
40. MONTANE B, Zhang S, Wolfe JD, Prime S, et al
    Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-00253.
    PubMed     Abstract available
    
    
    June 2025
41. SAEED A, Mulukutla SR, Thoma F, Lemon L, et al
    Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
    Ann Intern Med. 2025 Jun 17. doi: 10.7326/ANNALS-24-00775.
    PubMed     Abstract available
    
    
    
42. KATSANOS AH, Douketis JD
    In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01772.
    PubMed     Abstract available
    
    
    
43. BATUR P
    Some combined and progestin-only contraceptives were linked to increased risk for ischemic stroke and myocardial infarction.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01774.
    PubMed     Abstract available
    
    
    May 2025
44. ALBERTS MJ
    In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01330.
    PubMed     Abstract available
    
    
    
45. LO B
    In ischemic stroke, IV thrombolysis >4.5 h after symptom onset vs. standard medical care improves 90-d functional outcomes.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01326.
    PubMed     Abstract available
    
    
    
46. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    PubMed     Abstract available
    
    
    
47. DONATO AA, Rahimian S
    Non-vitamin K oral anticoagulants and aspirin do not differ for major bleeding and intracranial hemorrhage at a mean 20 mo.
    Ann Intern Med. 2025;178:JC58.
    PubMed     Abstract available
    
    
    April 2025
48. ABDEL-QADIR H, Gunn M, Fang J, Odugbemi T, et al
    Risk for Stroke After Newly Diagnosed Atrial Fibrillation During Hospitalization for Other Primary Diagnoses : A Retrospective Cohort Study.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-24-01967.
    PubMed     Abstract available
    
    
    
49. YNALVEZ LA, Deswal A
    In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 y.
    Ann Intern Med. 2025;178:JC43.
    PubMed     Abstract available
    
    
    
50. WANG Y, Lip GYH
    In HF with mildly reduced or preserved ejection fraction, finerenone reduced CV death and worsening HF, regardless of baseline LVEF.
    Ann Intern Med. 2025;178:JC44.
    PubMed     Abstract available
    
    
    February 2025
51. LEE YJ, Gao X, Lee SH, Kan J, et al
    De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome : A Systemic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials.
    Ann Intern Med. 2025 Feb 18. doi: 10.7326/ANNALS-24-03102.
    PubMed     Abstract available
    
    
    
52. SMETANA GW, Gelfand EV, Tung P, Burns RB, et al
    How Would You Manage This Patient With Recent-Onset Atrial Fibrillation? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2025 Feb 11. doi: 10.7326/ANNALS-24-03490.
    PubMed     Abstract available
    
    
    
53. SHARMA M, Srivastava A
    In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03879.
    PubMed     Abstract available
    
    
    
54. KOROMPOKI E, Douketis JD
    In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03608.
    PubMed     Abstract available
    
    
    
55. RACO MD, Raco DL
    In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03735.
    PubMed     Abstract available
    
    
    January 2025
56. EAPEN BC, Tran J, Ballard-Hernandez J, Buelt A, et al
    Stroke Rehabilitation: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.
    Ann Intern Med. 2025 Jan 21. doi: 10.7326/ANNALS-24-02205.
    PubMed     Abstract available
    
    
    
57. BATES ER
    In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y, regardless of duration of recent subclinical AF episodes.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
    PubMed     Abstract available
    
    
    
58. MORENO R
    In asymptomatic severe AS, early surgery vs. conservative therapy reduced a composite of death, MI, stroke, or HF hospitalization at 63 mo.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03367.
    PubMed     Abstract available
    
    
    December 2024
59. DONATO AA, Goswami V
    In acute ischemic stroke and a large infarct, adding EVT to medical treatment improved functional outcome at 12 mo.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02886.
    PubMed     Abstract available
    
    
    
60. LIBMAN H, Anderson TS, Rangan VV, Reynolds EE, et al
    How Would You Manage This Patient With Gastroesophageal Reflux Symptoms? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2024;177:1695-1701.
    PubMed     Abstract available
    
    
    November 2024
61. ROMITI GF, Talerico G
    In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA(2)DS(2)-VASc >4.
    Ann Intern Med. 2024;177:JC125.
    PubMed     Abstract available
    
    
    October 2024
62. WOODRUFF RC, Kaholokula JK, Riley L, Tong X, et al
    Cardiovascular Disease Mortality Among Native Hawaiian and Pacific Islander Adults Aged 35 Years or Older, 2018 to 2022.
    Ann Intern Med. 2024 Oct 15. doi: 10.7326/M24-0801.
    PubMed     Abstract available
    
    
    
63. SHARMA M, Srivastva A
    In ischemic stroke treated within 4.5 h, reteplase vs. alteplase increased excellent functional outcome at 90 d.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/ANNALS-24-02228.
    PubMed     Abstract available
    
    
    
64. DAVIDSON MB
    In adults with hypertension and high CV risk, intensive vs. standard BP-lowering therapy reduced major vascular events.
    Ann Intern Med. 2024;177:JC111.
    PubMed     Abstract available
    
    
    September 2024
65. KODUMURI N, Siddu M, Jillella D
    In acute ischemic stroke with a large core infarct, endovascular thrombectomy reduced disability at 90 d.
    Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-01578.
    PubMed     Abstract available
    
    
    August 2024
66. DUNBAR KB
    Gastroesophageal Reflux Disease.
    Ann Intern Med. 2024;177:ITC113-ITC128.
    PubMed     Abstract available
    
    
    
67. CLIFFORD C, Yan AT
    After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.
    Ann Intern Med. 2024;177:JC86.
    PubMed     Abstract available
    
    
    July 2024
68. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    PubMed     Abstract available
    
    
    
69. BARNES GD
    In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00652.
    PubMed     Abstract available
    
    
    June 2024
70. SEBASTIAN IA, Hill MD
    In ischemic stroke, adding IV thrombolysis
    Ann Intern Med. 2024 Jun 4. doi: 10.7326/ANNALS-24-00519.
    PubMed     Abstract available
    
    
    
71. WEITZ HH, Merli GJ, Lip GYH
    Annals Consult Guys - The ABCs of Atrial Fibrillation.
    Ann Intern Med. 2024;177:e2400618CG.
    PubMed    
    
    
    
72. FIELD TS
    In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin.
    Ann Intern Med. 2024;177:JC65.
    PubMed     Abstract available
    
    
    
73. CHIA JE, Mukherjee D
    After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
    Ann Intern Med. 2024;177:JC64.
    PubMed     Abstract available
    
    
    May 2024
74. XU W, Lee AL, Lam CLK, Danaei G, et al
    Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults : Real-World Evidence From a Target Trial Emulation Study.
    Ann Intern Med. 2024 May 28. doi: 10.7326/M24-0004.
    PubMed     Abstract available
    
    
    
75. ALBERTS MJ
    In mild ischemic stroke or high-risk TIA, DAPT started
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0029.
    PubMed     Abstract available
    
    
    
76. LI XRC
    Web Exclusive. Annals Graphic Medicine - Life After a Stroke.
    Ann Intern Med. 2024;177:eG230020.
    PubMed    
    
    
    
77. DUNN A
    In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
    Ann Intern Med. 2024;177:JC57.
    PubMed     Abstract available
    
    
    April 2024
78. DRAKE T, Landsteiner A, Langsetmo L, MacDonald R, et al
    Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.
    Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-1490.
    PubMed     Abstract available
    
    
    
79. QASEEM A, Obley AJ, Shamliyan T, Hicks LA, et al
    Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians.
    Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-2788.
    PubMed     Abstract available
    
    
    
80. AJZENBERG H, Binhashr MAN, Hewitt MK, Unger M, et al
    Critical Care: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0565.
    PubMed     Abstract available
    
    
    March 2024
81. SHADRIN IY, Newby LK
    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
    Ann Intern Med. 2024;177:JC26.
    PubMed     Abstract available
    
    
    February 2024
82. KANJEE Z, Dearborn-Tomazos JL, Kumar S, Reynolds EE, et al
    How Would You Prevent Subsequent Strokes in This Patient? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2024 Feb 13. doi: 10.7326/M23-3136.
    PubMed     Abstract available
    
    
    January 2024
83. FU EL, Carrero JJ, Sang Y, Evans M, et al
    Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C.
    Ann Intern Med. 2024 Jan 30. doi: 10.7326/M23-1138.
    PubMed     Abstract available
    
    
    
84. HILL MD
    After EVT for ischemic stroke, intensive vs. conventional BP management reduced functional independence at 3 mo.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0106.
    PubMed     Abstract available
    
    
    December 2023
85. SUD M, Sivaswamy A, Austin PC, Anderson TJ, et al
    Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2023 Dec 12. doi: 10.7326/M23-1345.
    PubMed     Abstract available
    
    
    
86. AGARWAL R, Tu W, Farjat AE, Farag YMK, et al
    Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
    Ann Intern Med. 2023 Dec 5. doi: 10.7326/M23-1023.
    PubMed     Abstract available
    
    
    
87. WEITZ HH, Merli GJ, Benesch C
    Annals Consult Guys - Surgery After Thromboembolic Stroke.
    Ann Intern Med. 2023;176:eW220025.
    PubMed    
    
    
    November 2023
88. TANG M, Nakamoto CH, Stern AD, Zubizarreta JR, et al
    Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension : An Observational Study.
    Ann Intern Med. 2023 Nov 7. doi: 10.7326/M23-1182.
    PubMed     Abstract available
    
    
    
89. CRUZ-FLORES S
    In healthy older adults, low-dose aspirin did not differ from placebo for ischemic stroke but increased intracranial bleeding.
    Ann Intern Med. 2023 Nov 7. doi: 10.7326/J23-0092.
    PubMed     Abstract available
    
    
    
90. TANNU M, Newby LK
    In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding.
    Ann Intern Med. 2023;176:JC123.
    PubMed     Abstract available
    
    
    October 2023
91. EASTIN C
    In minor, nondisabling, acute ischemic stroke, DAPT was noninferior to IV alteplase for excellent functional outcome at 90 d.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/J23-0072.
    PubMed     Abstract available
    
    
    
92. ALBERTS MJ
    In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/J23-0074.
    PubMed     Abstract available
    
    
    September 2023
93. RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
    Blood Pressure Level in Late Adolescence and Risk for Cardiovascular Events : A Cohort Study.
    Ann Intern Med. 2023 Sep 26. doi: 10.7326/M23-0112.
    PubMed     Abstract available
    
    
    
94. KIM DH, Lee SB, Park CM, Levin R, et al
    Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M22-3021.
    PubMed     Abstract available
    
    
    
95. BANNOW BTS
    In adults with cancer and VTE, DOACs were noninferior to LMWH for recurrent, nonfatal VTE at 6 mo.
    Ann Intern Med. 2023;176:JC104.
    PubMed     Abstract available
    
    
    August 2023
96. CARLIN S, Douketis J
    In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level.
    Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0054.
    PubMed     Abstract available
    
    
    
97. BAHREINI M, Lang E
    In ischemic stroke, EVT improved 90-d function more than usual care across admission SBP levels.
    Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0055.
    PubMed     Abstract available
    
    
    
98. KIRSCHNER JM, Hunter BR
    SAEM issued 4 strong recommendations (high-certainty evidence) for determining cause of acute vestibular syndrome in the ED.
    Ann Intern Med. 2023;176:JC86.
    PubMed     Abstract available
    
    
    July 2023
99. MCCORMICK N, Yokose C, Wei J, Lu N, et al
    Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0724.
    PubMed     Abstract available
    
    
    
100. ESKIN B
     In ischemic stroke, adding EVT to usual care at 6 to 24 h improved functional status at 90 d.
     Ann Intern Med. 2023 Jul 4. doi: 10.7326/J23-0050.
     PubMed     Abstract available
     
     
     
101. AL-KHATIB SM
     Atrial Fibrillation.
     Ann Intern Med. 2023;176:ITC97-ITC112.
     PubMed     Abstract available
     
     
     June 2023
102. FERGUSON E, Lang E
     In large acute ischemic stroke, adding endovascular thrombectomy to medical therapy improved function at 90 d.
     Ann Intern Med. 2023 Jun 6. doi: 10.7326/J23-0033.
     PubMed     Abstract available
     
     
     
103. ALBERTS MJ
     After ICH, starting long-term therapeutic oral anticoagulation in patients with AF reduces MACE at 1 to 3 y.
     Ann Intern Med. 2023;176:JC71.
     PubMed     Abstract available
     
     
     May 2023
104. RAY WA, Chung CP, Stein CM, Smalley W, et al
     Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study.
     Ann Intern Med. 2023 May 23. doi: 10.7326/M22-3238.
     PubMed     Abstract available
     
     
     
105. RICHARDSON TL JR, Halvorson AE, Hackstadt AJ, Hung AM, et al
     Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.
     Ann Intern Med. 2023 May 9. doi: 10.7326/M22-2751.
     PubMed     Abstract available
     
     
     
106. ZHU J, Kamel H, Gupta A, Mushlin AI, et al
     Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness Analysis.
     Ann Intern Med. 2023 May 2. doi: 10.7326/M22-3186.
     PubMed     Abstract available
     
     
     
107. GRIFFIN M, Lip GYH
     In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death.
     Ann Intern Med. 2023;176:JC56.
     PubMed     Abstract available
     
     
     April 2023
108. MARCUCCI M, Painter TW, Conen D, Lomivorotov V, et al
     Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial.
     Ann Intern Med. 2023 Apr 25. doi: 10.7326/M22-3157.
     PubMed     Abstract available
     
     
     
109. ADIE SK, Konerman MC
     Annals for Hospitalists Inpatient Notes - Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction-What Hospitalists Need to Know.
     Ann Intern Med. 2023;176:eM230588.
     PubMed    
     
     
     
110. LADER EW
     After PCI and 6 to 18 mo of DAPT, clopidogrel reduced a composite of clinical events vs. aspirin at 6 y.
     Ann Intern Med. 2023;176:JC38.
     PubMed     Abstract available
     
     
     
111. PERISETTI A, Sharma P
     In older patients receiving aspirin, H pylori eradication reduced hospitalization or death due to peptic ulcer bleeding at 2.5 y.
     Ann Intern Med. 2023;176:JC45.
     PubMed     Abstract available
     
     
     March 2023
112. FORD ND, DeSisto CL, Galang RR, Kuklina EV, et al
     Cardiac Arrest During Delivery Hospitalization : A Cohort Study.
     Ann Intern Med. 2023 Mar 14. doi: 10.7326/M22-2750.
     PubMed     Abstract available
     
     
     
113. CHEW DS, Piccini JP
     Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.
     Ann Intern Med. 2023;176:eL220517.
     PubMed    
     
     
     
114. ANDERSON CE, Lieberman RA, Olshansky B
     Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.
     Ann Intern Med. 2023;176:eL220516.
     PubMed    
     
     
     
115. DUNN A
     In AF, underdosing of DOACs was not linked to reduced bleeding.
     Ann Intern Med. 2023;176:JC32.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum